Werewolf Therapeutics, Inc. (HOWL)
NASDAQ: HOWL · Real-Time Price · USD
2.070
+0.050 (2.48%)
At close: Sep 26, 2025, 4:00 PM EDT
2.070
0.00 (0.01%)
After-hours: Sep 26, 2025, 7:59 PM EDT
Werewolf Therapeutics Stock Forecast
Stock Price Forecast
According to 5 professional analysts, the 12-month price target for Werewolf Therapeutics stock ranges from a low of $3.00 to a high of $15. The average analyst price target of $7.20 forecasts a 247.83% increase in the stock price over the next year.
Price Target: $7.20 (+247.83%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Aug 25, 2025.
Analyst Ratings
The average analyst rating for Werewolf Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 | Sep '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 2 | 2 |
| Buy | 2 | 2 | 2 | 2 | 3 | 3 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| B of A Securities | B of A Securities | Strong Buy Maintains $9 → $8 | Strong Buy | Maintains | $9 → $8 | +286.47% | Aug 25, 2025 |
| JMP Securities | JMP Securities | Buy Maintains $4 → $3 | Buy | Maintains | $4 → $3 | +44.93% | Aug 21, 2025 |
| Wedbush | Wedbush | Buy Maintains $8 → $6 | Buy | Maintains | $8 → $6 | +189.86% | May 9, 2025 |
| Wedbush | Wedbush | Buy Reiterates $8 | Buy | Reiterates | $8 | +286.47% | Mar 12, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $15 | Strong Buy | Reiterates | $15 | +624.64% | Mar 12, 2025 |
Financial Forecast
Revenue This Year
n/a
from 1.89M
Revenue Next Year
n/a
EPS This Year
-1.59
from -1.63
EPS Next Year
-1.40
from -1.59
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | n/a | n/a | |||
| Avg | n/a | n/a | |||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -1.48 | -0.84 | |||
| Avg | -1.59 | -1.40 | |||
| Low | -1.71 | -1.73 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.